IMMUCELL CORP (ICCC) Stock Income Statement
NASDAQ:ICCC - Nasdaq - US4525253062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 27.30M | 26.49M | 17.47M | 18.57M | 19.24M | |||
| Cost Of Goods | 18.30M | 18.55M | 13.60M | 10.92M | 10.59M | |||
| Gross Profit | 9.00M | 7.94M | 3.87M | 7.65M | 8.66M | |||
| Operating Expenses | 9.22M | 9.58M | 9.62M | 9.95M | 8.40M | |||
| Research and Development | 3.39M | 3.90M | 4.39M | 4.49M | 4.17M | |||
| Selling, General, and Administrative Expenses | 5.83M | 5.68M | 5.22M | 5.45M | 4.23M | |||
| Operating Income | -222.50K | -1.64M | -5.75M | -2.30M | 260.00K | |||
| Interest Income/Expense | -445.10K | -491.00K | -379.00K | -200.00K | -300.00K | |||
| Other Income/Expense | N/A | -507.00K | 100.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | 365.10K | N/A | N/A | |||
| Income Before Taxes | -261.20K | -2.15M | -5.77M | -2.49M | -70.00K | |||
| Income Tax | 10.50K | 10.10K | 4.60K | 10.00K | 10.00K | |||
| Net Income | -271.70K | -2.16M | -5.77M | -2.49M | -80.00K | |||
| EBITDA | 2.47M | 1.05M | -3.03M | 190.00K | 2.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.06 | -0.26 | -0.75 | -0.32 | -0.01 | |||
| Non GAAP EPS | -0.07 | -0.29 | -0.75 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 32.96% | 29.97% | 22.15% | 41.20% | 45.01% | |||
| Profit Margin | -1.00% | -8.14% | -33.05% | -13.41% | -0.42% | |||
| Operating Profit Margin | -0.81% | -6.19% | -32.90% | -12.39% | 1.35% | |||
All data in USD